Live feed
Filing
SC 13G/A
SC 13G/A0001086364-24-006950·Arbutus Biopharma Corp
Schedule 13G ownership disclosure
Arbutus Biopharma Corp
Security class unavailable
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,390,300
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001086364-24-006950
- Form type
- SC 13G/A
- Filer
- Arbutus Biopharma Corp
- CIK
- CIK 1447028
- Filed
- Feb 12, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership